Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes

EMBO Journal

Volumn 14, Issue 19, 1995, Pages 4814-4826

  Steiner, Philipp ^a   Philipp, Angelika ^a   Lukas, Jiri ^a,b   Godden Kent, Dee ^a,c   Pagano, Michele ^a,d   Mittnacht, Sybille ^a,c   Bartek, Jiri ^a,b   Eilers, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d GPC Biotech Inc   (United States)

Author keywords

Cell cycle; Cyclin D1; Cyclin E; Myc; Retinoblastoma protein

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; GROWTH FACTOR; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALIA; RODENTIA;

EID: 0029094329     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1995.tb00163.x     Document Type: Article

References (83)

1. Amati,B. and Land,H. (1994) Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr. Opin. Genet. Dev., 4, 102-108.
2. Armelin,H.A., Armelin,M.C.S., KeIly,K., Stewart,T., Leder,P., Cochran,B.H. and Stiles,C.D. (1984) Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature, 310, 655-660.
3. Ayer,D.E., Kretzner,L. and Eisenman,R.N. (1993) Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell, 72, 211-222.
4. Ayer,D.E., Lawrence,Q.A. and Eisenman,R.N. (1995) Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast represser Sin3. Cell, 80, 767-776.
5. Baldin,V., Lukas,J., Marcote,M.J., Pagano,M. and Draetta,G. (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev., 1, 812-821.
6. Bello-Fernandez,C., Packham,G. and Cleveland,J.L. (1993) The ornithine decarboxylase gene is a transcriptional target of c-MYC. Proc. Natl Acad. Sci. USA, 90, 7804-7808.
7. Benvenisty,N., Leder,A., Kuo,A. and Leder,P. (1992) An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev., 6, 2513-2524.
8. Berry,M., Metzger,D. and Chambon,P. (1990) Role of the two activating domains of the oestrogen receptor in the cell-type and promotor-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J., 9, 2811-2818.
9. Blackwood,E.M. and Eisenman,R.N. (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with myc. Science, 251, 1211-1217.
10. Blackwood,E.M., Lüscher,B. and Eisenman,R.N. (1992) Myc and Max associate in vivo. Genes Dev., 6, 71-80.
11. Castellazzi,M., Spyrou,G., LaVista,N., Dangy,J.-P., Piu,F., Yaniv,M. and Brun,G. (1991) Overexpression of c-jun, junB, or junD affects cell growth differently. Proc. Natl Acad. Sci. USA, 88, 8890-8894.
12. Daksis,J.I., Lu,R.Y., Facchini,L.M., Marhin,W.W. and Penn,L.J.Z. (1994) Myc induces cyclin Dl expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene, 9, 3635-3645.
13. Danielian,P.S., White,R., Hoare,S.A., Fawell,S.E. and Parker,M.G. (1993) Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol. Endocrinol., 7, 232-240.
14. Davis,A.C., Wims,M., Spotts,G.D., Hann,S.R. and Bradley,A. (1993) A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7, 671-682.
15. Dulic,V., Lees,E. and Reed,S.I. (1992) Association of human cyclin E with a periodic G1-phase protein kinase. Science, 257, 1958-1961.
16. Eilers,M., Picard,D., Yamamoto,K. and Bishop,J.M. (1989) Chimaeras between the MYC oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature, 340, 66-68.
17. Eilers,M., Schirm,S. and Bishop,J.M. (1991) The MYC protein activates transcription of the α-prothymosin gene. EMBO J., 10, 133-141.
18. El-Deiry,W.S. et al. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res, 54, 1169-74.
19. Evan,G.I. Lewis,G.K., Ramsay,G. and Bishop,J.M. (1985) Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol., 5, 3610-3616.
20. Evan,G.I., Wyllie,A.H., Gilbert,C.S., Littlewood,T.D., Land,H., Brooks,M., Waters,C.M., Penn,L.Z. and Hancock,D.C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
21. Fisher,R.P. and Morgan,D.O. (1994) A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell, 78, 713-724.
22. Galaktionov,K., Jessus,C. and Beach,D. (1995) Raf1 interaction with cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev., 9, 1046-1058.
23. Gaubatz,S., Meichle,A. and Eilers,M. (1994) An E-box element localized in the first intron mediates regulation of the prothymosin a gene by c-myc. Mol. Cell. Biol., 14, 3853-3862.
24. Gu,W., Cechova,K., Tassi,V. and Dalla-Favera,R. (1993) Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc. Natl Acad. Sci. USA, 90, 2935-2939.
25. Gu,Y., Rosenblatt,J. and Morgan,D.O. (1992) Cell cycle regulation of CDK2 activity by phosphorylation of the Thr160 and Tyr15. EMBO J., 11, 3995-4005.
26. Gu,Y., Turek,C.W. and Morgan,D.O. (1993) Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature, 366, 707-710.
27. INK4b is a potential effector of cell cycle arrest mediated by TGF-β. Nature, 371, 257-261.
28. Hanson,K.D., Shichiri,M., Follansbee,M.R. and Sedivy,J.M. (1994) Effects of c-myc expression on cell cycle progression. Mol. Cell. Biol., 14, 5748-5755.
29. Harper,J.W., Adami,G.R., Wei,N., Keyomarsi,K. and Elledge,S.J. (1993) The p21 cdk-interaction protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
30. 1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev., 8, 1759-1771.
31. Heikkila,R., Schwab,G., Wickstrom,E., Loke,S.L., Piuznik,D.H., Watt,R. and Neckers,L.M. (1987) A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature, 328, 445-449.
32. Herber,B., Truss,M, Beato,M. and Muller,R. (1994) Inducible regulatory elements in the human cyclin D1 promoter. Oncogene, 9, 1295-304.
33. Herrlich,P. and Ponta,H. (1989) Nuclear oncogenes convert extracellular stimuli into changes in the genetic program. Trends Genet., 5, 112-116.
34. Hoang,A.T., Cohen,K.J., Barrett,J.F., Bergstrom,D.A. and Dang,C.V. (1994) Participation of cyclin A in Myc-induced apoptosis. Proc. Natl Acad. Sci. USA, 91, 6875-6879.
35. 1/S transition. EMBO J., 13, 4302-4310.
36. Jansen-Dürr,P., Meichle,A., Steiner,P., Pagano,M., Finke,K., Botz,J., Wessbecher,J., Draetta,G. and Eilers,M. (1993) Differential modulation of cyclin gene expression by MYC. Proc. Natl Acad. Sci. USA, 90, 3685-3689.
37. Jiang,W., Kahn,S.M., Zhou,P., Zhang,Y.-J., Cacace,A.M., Infante,A.S., Doi,S., Santella,R.M. and Weinstein,I.B. (1993) Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8, 3447-3457.
38. Jinno,S., Suto,K., Nagatu,A., Igarashi,M., Kanaoka,Y., Nojima,H. and Okayama,H. (1994) Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J., 13, 1549-1556.
39. Kaczmarek,L., Miller,M.R., Hammond,R.A. and Mercer,W.E. (1986) A microinjected monoclonal antibody against human DNA polymerase-A inhibits DNA replication in human, hamster and mouse cell lines. J. Biol. Chem., 261, 10802-10807.
40. Keath,E.J., Caimi,P.G. and Cole,M.D. (1984) Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngenic animals. Cell, 39, 339-348.
41. Kelly,K. and Siebenlist,U. (1986) The regulation and expression of c-myc in normal and malignant cells. Annu. Rev. Immunol., 4, 317-338.
42. Kelly,K., Cochran,B.H., Stiles,C.D. and Leder,P. (1983) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell, 35, 603-610.
43. Kirschmeier,P.T., Housey,G.M., Johnson,M.D., Perkins,A.S. and Weinstein,B. (1988) Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences. DNA, 7, 219-225.
44. Kumar,V., Green,S., Staub,A. and Chambon,P. (1986) Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J., 5, 2231-2236.
45. Land,H., Chen,A.C., Morgenstern,J.P., Parada,L.F. and Weinberg,R.A. (1986) Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol. Cell. Biol., 6, 1917-1925.
46. Langdon,W.Y., Harris,A.W., Cory,S. and Adams,J.M. (1986) The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice. Cell, 47, 11-18.
47. Littlewood,T.D., Hancock,D.C., Danielian,P.S., Parker,M.G. and Evan,G.I. (1995) A modified oestrogen receptor ligand binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res., 23, 1686-1690.
48. Lovec,H., Sewing,A., Lucibello,F.C., Müller,R. and Möröy,T. (1994) Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene, 9, 323-326.
49. Lukas,J., Müller,H., Bartkova,J., Spitkovksy,D., Kjerulff,A.A., Jansen-Dürr,P., Strauss,M. and Bartek,J. (1994a) DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J. Cell Biol., 125, 625-638.
50. Lukas,J., Pagano,M., Staskova,Z., Draetta,G. and Bartek,J. (1994b) Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene, 9, 707-718.
51. Markowitz,D., Goff,S. and Bank,A. (1988) A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol., 62, 1120-1124.
52. Matsuoka,M., Kato,J.-Y., Fisher,R.P., Morgan,D.O. and Sherr,C.J. (1994) Activation of cyclin-dependent kinase-4 (CDK4) by mouse MO15-associated kinase. Mol. Cell Biol., 14, 7265-7275.
53. Matsushime,H., Quelle,D.E., Shurtleff,S.A., Shibuya,M., Sherr,C.J. and Kato,J.-Y. (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14, 2066-2076.
54. Meichle,A., Philipp,A. and Eilers,M. (1992) The functions of Myc proteins. Biochim. Biophys. Acta, 1114, 129-146.
55. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol., 14, 2077-2086.
56. Morgan,D. (1995) Principles of CDK regulation. Nature, 374, 131-134.
57. Muller,R., Mumberg,D. and Lucibello,F.C. (1993) Signals and genes in the control of cell-cycle progression. Biochim. Biophys. Acta, 1155, 151-179.
58. Nakabeppu,Y., Oda,S. and Sekiguchi,M. (1993) Proliferative activation of quiescent rat-1A cells by ΔFosB. Mol. Cell. Biol., 13, 4157-4166.
59. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature, 372, 570-573.
60. Oswald,F., Lovec,H., Möröy,T. and Lipp,M. (1994) E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oncogene, 9, 2029-2036.
61. Pagano,M., Pepperkok,R., Lukas,J., Baldin,V., Ansorge,W., Bartek,J. and Draetta,G. (1993) Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J. Cell Biol., 121, 101-111.
62. Pagano,M., Tam,S.W., Theodoras,A.M., Del Sal,G., Yew,P.R., Draetta,G.F. and Rolfe,M. (1995) p27 levels are cell cycle-regulated by the ubiquitin-proteasome pathway. Science, 269, 682-685.
63. Philipp,A., Schneider,A., Väsrik,I., Finke,K., Xiong,Y., Beach,D., Alitalo,K. and Eilers,M. (1994) Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol., 14, 4032-4043.
64. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8, 9-22.
65. Polyak,K., Lee,M.-H., Erdjument-Bromage,H., Koff,A., Roberts,J.M., Tempst,P. and Massague,J. (1994b) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66.
66. Prendergast,G.C., Lawe,D. and Ziff,E.B. (1991) Association of myn, the murine homolog of max, with c-myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell, 65, 395-407.
67. Prochownik,E.V., Kukowska,J. and Rodgers,C. (1988) c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells. Mol. Cell. Biol., 8, 3683-3695.
68. Quelle,D.E., Ashmun,R.A., Shurtleff,S.A., Kato,J.Y., Bar-Sagi,D., Roussel,M.F. and Sherr,C.J. (1993) Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev., 7, 1559-1571.
69. Reisman,D., Elkind,N.B., Roy,B., Beamon,J. and Rotter,V. (1993) c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. Cell Growth Differential, 4, 57-65.
70. Rustgi,A.K., Dyson,N. and Bernards,R. (1991) Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature, 352, 541-544.
71. Schreiber-Agus,N., Chin,L., Chen,K., Torres,R., Rao,G., Guida,P., Skoultchi,A.I. and DePinho,R.A. (1995) An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional represser SIN1. Cell, 80, 777-786.
72. Sebastian,B., Kakizuka,A. and Hunter,T. (1993) Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc. Natl Acad. Sci. USA, 90, 3521-3524.
73. Serrano,M., Hannon,G.J. and Beach,D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707.
74. Sherr,C.J. (1994) G1 phase progression: cycling on cue. Cell, 79, 551-555.
75. Solomon,D., Philipp,A., Land,H. and Eilers,M. (1995) Expression of cyclin D1 mRNA is not upregulated by Myc in rat fibroblasts. Oncogene, in press.
76. Toyoshima,H. and Hunter,T. (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
77. Van den Heuvel,S. and Harlow,E. (1993) Distinct roles for cyclin-dependent kinases in cell cycle control. Science, 262, 2050-2053.
78. Weinberg,R.A. (1995) The retinoblastoma protein and cell cycle control Cell 81, 323-330.
79. Westin,E.H., Gallo,R.C., Arya,S.K., Eva,A., Souza,L.M., Baluda,M.A., Aaronson,S.A. and Wong-Staal,F. (1982a) Differential expression of the amv gene in human hematopoietic cells. Proc. Natl Acad. Sci. USA, 79, 2194-2198.
80. Westin,E.H. et al. (1982b) Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc. Natl Acad. Sci. USA, 79, 2490-2494.
81. Won,K.-A., Xiong,Y., Beach,D. and Gilman,M.Z. (1992) Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl Acad. Sci. USA, 89, 9910-9914.
82. Xiong,Y., Hannon,G.J., Zhang,H., Casso,D., Kobayashi,R. and Beach,D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701-710.
83. Zervos,A.S., Gyuris,J. and Brent,R. (1993) Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell, 72, 223-232.